Applied Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Applied Biosciences Corp
APPB Stock  USD 0.0001  0.00  0.000003%   
Applied Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Applied Biosciences' valuation are provided below:
Gross Profit
528.3 K
Market Capitalization
2.2 K
Enterprise Value Revenue
0.082
Revenue
859.9 K
Quarterly Revenue Growth
(0.59)
We have found one hundred twenty available fundamental signals for Applied Biosciences Corp, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Applied Biosciences Corp prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Applied Biosciences Total Revenue

853,777

Check Applied Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Biosciences' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 783.5 K or Selling General Administrative of 3.4 M, as well as many indicators such as Price To Sales Ratio of 33.78, Dividend Yield of 0.0 or Days Sales Outstanding of 48.26. Applied financial statements analysis is a perfect complement when working with Applied Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Applied Stock
Check out the analysis of Applied Biosciences Correlation against competitors.

Applied Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities451.9 K430.4 K212.9 K
Slightly volatile
Accounts Payable336.3 K320.3 K156.1 K
Slightly volatile
Total Liabilities451.9 K430.4 K212.9 K
Slightly volatile
Common Stock136155123
Slightly volatile
Net Receivables197.3 K187.9 K93 K
Slightly volatile
Net Invested Capital1.6 M2.5 M1.4 M
Slightly volatile
Capital Stock108122133
Slightly volatile

Applied Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative3.4 M3.2 M1.7 M
Slightly volatile
Total Operating Expenses4 M3.9 M2 M
Slightly volatile
Reconciled Depreciation34.7 K36.6 K126.7 K
Slightly volatile

Applied Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings1.3 M1.8 M1 M
Slightly volatile
Depreciation84 K46.7 K45.9 K
Pretty Stable
Capital Expenditures1.3 K1.4 K3 K
Slightly volatile
Total Cash From Financing Activities961.3 K1.8 M957.9 K
Slightly volatile
Change To Netincome872.6 K1.1 M738.7 K
Slightly volatile
Change To Liabilities24.4 K41.3 K29.7 K
Slightly volatile
End Period Cash Flow40.2 K42.3 K115.4 K
Slightly volatile
Other Non Cash Items800.2 K974.1 K739.2 K
Slightly volatile
Stock Based Compensation847 K952.9 K1 M
Slightly volatile
Issuance Of Capital Stock60 K67.5 K73.7 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio33.7835.552.4 K
Slightly volatile
Days Sales Outstanding48.2626.1837.4527
Slightly volatile
Average Payables413.8 K394.1 K229.7 K
Slightly volatile
Stock Based Compensation To Revenue1.421.350.781
Slightly volatile
Capex To Depreciation0.00.03.0989
Slightly volatile
EV To Sales37.1339.092.4 K
Slightly volatile
Inventory Turnover3.143.082.3924
Slightly volatile
Days Of Inventory On Hand117123593
Slightly volatile
Payables Turnover0.920.971.1618
Very volatile
Sales General And Administrative To Revenue3.993.43.2197
Pretty Stable
Average Inventory31 K57.5 K37.1 K
Slightly volatile
Capex To Revenue0.01.0E-41.3575
Slightly volatile
Cash Per Share0.00.00.0038
Very volatile
Days Payables Outstanding415498514
Slightly volatile
Income Quality0.641.120.7804
Pretty Stable
Intangibles To Total Assets0.520.310.4899
Slightly volatile
Current Ratio0.01490.01571.5774
Slightly volatile
Receivables Turnover8.8614.4311.5249
Slightly volatile
Average Receivables98.5 K93.8 K55 K
Slightly volatile
Revenue Per Share0.00550.00580.0115
Very volatile
Interest Debt Per Share0.03580.01790.0252
Slightly volatile
Debt To Assets0.230.251.052
Slightly volatile
Operating Cycle142149629
Slightly volatile
Days Of Payables Outstanding415498514
Slightly volatile
Ebt Per Ebit2.171.492.6249
Slightly volatile
Quick Ratio0.01490.01571.473
Slightly volatile
Net Income Per E B T1.050.980.955
Slightly volatile
Cash Ratio6.0E-46.0E-41.1641
Slightly volatile
Days Of Inventory Outstanding117123593
Slightly volatile
Days Of Sales Outstanding48.2626.1837.4527
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.321.151.4377
Slightly volatile
Fixed Asset Turnover0.270.2921.2004
Slightly volatile
Debt Ratio0.230.251.052
Slightly volatile
Price Sales Ratio33.7835.552.4 K
Slightly volatile
Asset Turnover0.05930.06250.0793
Pretty Stable

Applied Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.2 M2.5 M2.7 M
Slightly volatile
Enterprise Value2.4 M2.7 M3 M
Slightly volatile

About Applied Biosciences Financial Statements

Applied Biosciences stakeholders use historical fundamental indicators, such as Applied Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Applied Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Applied Biosciences' assets and liabilities are reflected in the revenues and expenses on Applied Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Applied Biosciences Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue813.1 K853.8 K
Cost Of Revenue600 K630 K
Stock Based Compensation To Revenue 1.35  1.42 
Sales General And Administrative To Revenue 3.40  3.99 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(7.03)(7.38)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc
When determining whether Applied Biosciences Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Biosciences Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Biosciences Corp Stock:
How To Invest In Applied
Details
Is Applied Stock a good investment?
Details
What is Applied Biosciences' Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Applied Biosciences Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Biosciences. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.063
Quarterly Revenue Growth
(0.59)
Return On Assets
(0.64)
Return On Equity
(2.22)
The market value of Applied Biosciences Corp is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Applied Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Biosciences' market value can be influenced by many factors that don't directly affect Applied Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Applied Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY